Free Trial

MeiraGTx (MGTX) Competitors

MeiraGTx logo
$7.09 +0.19 (+2.75%)
As of 04/30/2025 04:00 PM Eastern

MGTX vs. GLPG, IDYA, ARQT, TVTX, AGIO, HRMY, EWTX, IRON, INDV, and KNSA

Should you be buying MeiraGTx stock or one of its competitors? The main competitors of MeiraGTx include Galapagos (GLPG), IDEAYA Biosciences (IDYA), Arcutis Biotherapeutics (ARQT), Travere Therapeutics (TVTX), Agios Pharmaceuticals (AGIO), Harmony Biosciences (HRMY), Edgewise Therapeutics (EWTX), Disc Medicine (IRON), Indivior (INDV), and Kiniksa Pharmaceuticals (KNSA). These companies are all part of the "pharmaceutical products" industry.

MeiraGTx vs.

MeiraGTx (NASDAQ:MGTX) and Galapagos (NASDAQ:GLPG) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, community ranking, risk, media sentiment and institutional ownership.

67.5% of MeiraGTx shares are owned by institutional investors. Comparatively, 32.5% of Galapagos shares are owned by institutional investors. 8.4% of MeiraGTx shares are owned by company insiders. Comparatively, 2.9% of Galapagos shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

MeiraGTx currently has a consensus target price of $24.50, suggesting a potential upside of 245.56%. Galapagos has a consensus target price of $25.33, suggesting a potential downside of 5.89%. Given MeiraGTx's stronger consensus rating and higher probable upside, analysts plainly believe MeiraGTx is more favorable than Galapagos.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MeiraGTx
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Galapagos
4 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Galapagos has a net margin of 0.00% compared to MeiraGTx's net margin of -633.05%. Galapagos' return on equity of 0.00% beat MeiraGTx's return on equity.

Company Net Margins Return on Equity Return on Assets
MeiraGTx-633.05% -146.38% -53.05%
Galapagos N/A N/A N/A

In the previous week, Galapagos had 5 more articles in the media than MeiraGTx. MarketBeat recorded 13 mentions for Galapagos and 8 mentions for MeiraGTx. MeiraGTx's average media sentiment score of 0.97 beat Galapagos' score of 0.64 indicating that MeiraGTx is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
MeiraGTx
4 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Galapagos
4 Very Positive mention(s)
0 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Galapagos has higher revenue and earnings than MeiraGTx.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MeiraGTx$33.28M16.80-$84.03M-$2.13-3.33
Galapagos$288.19M6.16$80.16MN/AN/A

Galapagos received 273 more outperform votes than MeiraGTx when rated by MarketBeat users. However, 71.75% of users gave MeiraGTx an outperform vote while only 63.75% of users gave Galapagos an outperform vote.

CompanyUnderperformOutperform
MeiraGTxOutperform Votes
193
71.75%
Underperform Votes
76
28.25%
GalapagosOutperform Votes
466
63.75%
Underperform Votes
265
36.25%

MeiraGTx has a beta of 1.21, meaning that its stock price is 21% more volatile than the S&P 500. Comparatively, Galapagos has a beta of 0.16, meaning that its stock price is 84% less volatile than the S&P 500.

Summary

MeiraGTx beats Galapagos on 9 of the 16 factors compared between the two stocks.

Get MeiraGTx News Delivered to You Automatically

Sign up to receive the latest news and ratings for MGTX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MGTX vs. The Competition

MetricMeiraGTxBiological Products IndustryMedical SectorNASDAQ Exchange
Market Cap$559.08M$3.00B$5.56B$7.82B
Dividend YieldN/A1.89%5.11%4.22%
P/E Ratio-5.8630.4222.5718.48
Price / Sales16.80498.92395.64103.60
Price / CashN/A168.6838.1834.62
Price / Book3.273.206.774.25
Net Income-$84.03M-$72.35M$3.22B$248.23M
7 Day Performance8.24%1.46%1.46%0.89%
1 Month Performance15.10%8.79%3.98%3.53%
1 Year Performance42.08%-22.36%16.14%5.09%

MeiraGTx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MGTX
MeiraGTx
4.5461 of 5 stars
$7.09
+2.8%
$24.50
+245.6%
+45.3%$559.08M$33.28M-5.86300Upcoming Earnings
Short Interest ↑
Positive News
GLPG
Galapagos
0.6174 of 5 stars
$26.87
+0.0%
$25.33
-5.7%
-5.4%$1.77B$288.19M0.001,310Options Volume
High Trading Volume
IDYA
IDEAYA Biosciences
3.7112 of 5 stars
$19.75
+3.9%
$53.58
+171.3%
-50.5%$1.73B$7M-5.9880Upcoming Earnings
Positive News
High Trading Volume
ARQT
Arcutis Biotherapeutics
2.7588 of 5 stars
$14.53
-0.5%
$18.80
+29.4%
+79.2%$1.72B$196.54M-8.12150Upcoming Earnings
Positive News
Gap Down
TVTX
Travere Therapeutics
2.8971 of 5 stars
$19.36
+5.6%
$32.08
+65.7%
+276.3%$1.72B$233.18M-4.72460News Coverage
Positive News
AGIO
Agios Pharmaceuticals
4.2318 of 5 stars
$29.62
+0.6%
$56.57
+91.0%
-8.6%$1.70B$36.50M2.61390Analyst Revision
News Coverage
HRMY
Harmony Biosciences
4.8237 of 5 stars
$29.36
-0.8%
$52.44
+78.6%
-4.7%$1.68B$714.73M13.91200Upcoming Earnings
Analyst Forecast
Analyst Revision
News Coverage
Positive News
EWTX
Edgewise Therapeutics
3.2304 of 5 stars
$15.68
+5.7%
$40.13
+155.9%
-8.6%$1.64BN/A-10.4560Upcoming Earnings
Analyst Forecast
Short Interest ↑
IRON
Disc Medicine
2.3683 of 5 stars
$46.16
+1.6%
$93.80
+103.2%
+77.5%$1.60BN/A-11.6030Upcoming Earnings
News Coverage
Positive News
INDV
Indivior
3.3529 of 5 stars
$11.57
+0.1%
$15.00
+29.6%
-34.5%$1.60B$1.17B-33.061,164Earnings Report
Short Interest ↑
Analyst Revision
KNSA
Kiniksa Pharmaceuticals
2.4936 of 5 stars
$21.47
+0.5%
$37.17
+73.1%
+44.1%$1.56B$423.24M-153.35220Earnings Report
Analyst Forecast
Analyst Revision
News Coverage

Related Companies and Tools


This page (NASDAQ:MGTX) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners